Table 1.
Patient | Gender | Age | Age of onset | Diagnosis | BAD score | Age at BAD‐score | BAD/age | DNA mutation | Protein mutation | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Allele 1 | Allele 2 | Allele 1 | Allele 2 | ||||||||
P1 | ♂ | 21 | 2 | classical | 29 | 21 | 1,38 | c.573del | c.1274T > C | S191fs | L425P |
P2 | ♀ | 15 | 23 | atypical | 14 | 27 | 0,52 | c.573del | c.863C > G | S191fs | P288R |
P3 | ♂ | 25 | 1 | classical | 13 | 9 | 1,44 | c.1561G > A | c.1561G > A | G521R | G521R |
P4 | ♀ | 28 | 10 | atypical | 29 | 19 | 1,53 | c.1660G > A | c.1660G > A | E554K | E554K |
P5 | ♀ | 13 | 12 | atypical | 16 | 34 | 0,47 | c.1369G > T | c.1561G > A | D457Y | G521R |
P6 | ♂ | 23 | 3 | classical | 31 | 23 | 1,35 | c.1660G > A | c.1660G > A | E554K | E554K |
P7 | ♀ | 27 | 14 | atypical | 11 | 20 | 0,55 | c.573del | c.863C > G | S191fs | P288R |
P8 | ♀ | 22 | 11 | atypical | 11 | 13 | 0,85 | c.1420‐1426del | c.1583C > T | N474fs | T528M |
P9 | ♂ | 25 | 13 | atypical | 22 | 22 | 1,00 | c.1561G > A | c.1583C > T | G521R | T528M |
P10 | ♂ | 25 | 12 | atypical | 20 | 21 | 0,95 | c.1561G > A | c.1583C > T | G521R | T528M |
P11 | ♀ | 38 | 10 | atypical | 13 | 25 | 0,52 | c.1583C > T | c.1235 + 5G>A | T528M | ? |
P12 | ♂ | 36 | 2 | classical | 9 | 11 | 0,82 | c.833G > T | c.833G > T | R278L | R278L |
P13 | ♂ | 11 | 2 | classical | 9 | 36 | 0,25 | c.1583C > T | c.1583C > T | T528M | T528M |
P14 | ♂ | 25 | 16 | atypical | 12 | 23 | 0,52 | c.1583C > T | c.1583C > T | T528M | T528M |
The DNA mutations refer to the NCBI Reference Sequence: NM_153638.3 (pantothenate kinase 2 mRNA transcript variant 1). The c.1235 + 5G > A mutation of patient P11 is located in the intron 5 bases downstream the splice site after exon 3 and changes the consensus sequence from GTAAGT to GTAAAT which likely results in improper splicing.